http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525712-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 1995-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1996-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82acaf4a8bd215a5cbb8ab80df8b2296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87785ff8e004f732d87c538d39edd8f6 |
publicationDate | 1996-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-5525712-A |
titleOfInvention | DNA encoding the human neurokinin-1 receptor |
abstract | Recombinant human neurokinin-1 receptor (human NKIR) is disclosed which has been isolated by polymerase chain reaction techniques. Also disclosed is the complete sequence of human NKIR cDNA, expression systems containing said isolated cDNA, including a CHO (Chinese Hamster Ovarian Cell Line) stable expression systems, and an assay using the CHO eexpression system. NKIR, also known as substance P receptor, can be used in an assay to identify and evaluate entities that bind substance P receptor. The assay can also be used in conjunction with diagnosis and therapy to determine the body fluid concnetration of substance P in arthritis patients. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010000073-A1 |
priorityDate | 1991-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.